𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Circulating endothelial cells in patients with chronic lymphocytic leukemia : Clinical-prognostic and biologic significance

✍ Scribed by Gian Matteo Rigolin; Rossana Maffei; Lara Rizzotto; Maria Ciccone; Olga Sofritti; Giulia Daghia; Francesca Cibien; Francesco Cavazzini; Roberto Marasca; Antonio Cuneo

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
419 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The clinical significance of large cells
The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemia
✍ Yupo Ma; Adnan Mansour; B. Nebiyou Bekele; Xian Zhou; Michael J. Keating; Susan πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 253 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Patients with chronic lymphocytic leukemia (CLL) that transforms to Richter syndrome (RS) frequently show atypical lymphocytes in bone marrow; however, a diagnosis of RS requires confirmation of the presence of sheets of large cells in bone marrow or lymph nodes. ## METH

Enzymatic activity of circulating protea
Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia
✍ Wanlong Ma; Hagop Kantarjian; Susan O'Brien; Iman Jilani; Xi Zhang; Zeev Estrov; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 217 KB

## Abstract ## BACKGROUND The ubiquitin‐proteasome pathway has been implicated in the pathogenesis of many hematologic malignancies. ## METHODS The authors measured proteasome peptidase activity levels in plasma samples from 225 patients with chronic lymphocytic leukemia (CLL) and correlated the

Prognostic value of plasma interleukin-6
Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia
✍ Raymond Lai; Susan O'Brien; Taghi Maushouri; Anna Rogers; Hagop Kantarjian; Mich πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

## Background: Interleukin 6 (il-6) is a b-cell growth and differentiation factor, which may promote the growth of b-cell neoplasms. in chronic lymphocytic leukemia (cll) patients, il-6 plasma levels increased in a stage-dependent manner, suggesting that il-6 may be a useful prognostic marker. the

The clinical course of lung carcinoma in
The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia
✍ Kalpaj Parekh; Valerie Rusch; Mark Kris πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

## BACKGROUND. Although patients with chronic lymphocytic leukemia (CLL) have an increased risk of developing second primary malignancies, including lung carcinoma, there is virtually no information about their clinical outcomes. To evaluate this, the authors reviewed their 20-year institutional e